I agree that this site is using cookies. You can find further informations here.
X
Chong, Elise A.
87  results:
Search for persons X
?
1

Immunologic Predictors of Vaccine Responsiveness in Patient..:

Chong, Elise A ; Kumashie, Kingsley Gideon ; Chong, Emeline R...
The Journal of Infectious Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

CAR-T for large B-cell lymphomas: the clock is ticking:

Chong, Elise A.
Blood Advances.  8 (2024)  11 - p. 2980-2981 , 2024
Link: https://doi.org/10.1182/..
 
?
3

Bendamustine lymphodepletion before axicabtagene ciloleucel..:

Ghilardi, Guido ; Paruzzo, Luca ; Svoboda, Jakub...
Blood Advances.  8 (2024)  3 - p. 653-666 , 2024
Link: https://doi.org/10.1182/..
 
?
4

Bendamustine as Lymphodepletion for Brexucabtagene Autoleuc..:

Chong, Elise A. ; Chong, Emeline R. ; Therwhanger, Dylan...
Transplantation and Cellular Therapy.  30 (2024)  7 - p. 726.e1-726.e8 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Efficacy and safety of bendamustine for lymphodepletion bef..:

Ghilardi, Guido ; Paruzzo, Luca ; Patel, Vrutti...
Journal of Hematology & Oncology.  17 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

T cell lymphoma and secondary primary malignancy risk after..:

Ghilardi, Guido ; Fraietta, Joseph A. ; Gerson, James N....
Nature Medicine.  30 (2024)  4 - p. 984-989 , 2024
Link: https://doi.org/10.1038/..
 
?
7

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidenc..:

Bowers, Jackson T. ; Anna, Jacob ; Bair, Steven M....
Blood Advances.  7 (2023)  21 - p. 6630-6638 , 2023
Link: https://doi.org/10.1182/..
 
?
8

Modulation of the gut microbiota engages antigen cross-pres..:

Uribe-Herranz, Mireia ; Beghi, Silvia ; Ruella, Marco...
Molecular Therapy.  31 (2023)  3 - p. 686-700 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Survival Outcomes for Patients with Relapsed/ Refractory Ag..:

Landsburg, Daniel J. ; Nasta, Sunita D. ; Svoboda, Jakub...
Transplantation and Cellular Therapy.  29 (2023)  8 - p. 495-503 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Salvage radiotherapy for relapsed/refractory non‐Hodgkin ly..:

Yegya-Raman, Nikhil ; Wright, Christopher M. ; LaRiviere, Michael J....
Clinical and Translational Radiation Oncology.  39 (2023)  - p. 100587 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Mogamulizumab Multimodality Therapy with Systemic Retinoids..:

Weiner, David M. ; Rastogi, Supriya ; Lewis, Daniel J....
Dermatologic Therapy.  2023 (2023)  1 - p. , 2023
Link: https://doi.org/10.1155/..
 
?
12

TP53 mutations predict for poor outcomes in patients with n..:

Landsburg, Daniel J. ; Morrissette, Jennifer JD ; Nasta, Sunita D....
Blood Advances.  7 (2023)  23 - p. 7243-7253 , 2023
Link: https://doi.org/10.1182/..
 
?
13

Long Term Neurologic Outcomes for Patients Receiving CAR-T ..:

van Besien, Herman ; Porter, David L. ; Nasta, Sunita D....
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S200-S201 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Mutation analysis performed on tumor biopsies from patients..:

Landsburg, Daniel J. ; Morrissette, Jennifer J.D. ; Schuster, Stephen J....
Oncotarget.  13 (2022)  1 - p. 1237-1244 , 2022
Link: https://doi.org/10.18632..
 
?
15

Radiation Therapy for Relapsed or Refractory Diffuse Large ..:

Wright, Christopher M. ; Dreyfuss, Alexandra D. ; Baron, Jonathan A....
Advances in Radiation Oncology.  7 (2022)  6 - p. 101016 , 2022
Link: https://doi.org/10.1016/..
 
1-15